Publications
2008
The chemokine IL-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in CML.
Hantschel O,
Gstoettenbauer A,
Colinge J,
Kaupe I,
Bilban M,
Burkard TR,
Valent P,
Superti-Furga G.
Molecular Oncology, Vol 2/Issue3/ October 2008, 272–281.
2008
Structural coupling of Fes and Abl SH2-tyrosine kinase domains links substrate recognition and kinase activation.
Filippakopoulos P,
Kofler M,
Hantschel O,
Gish GD,
Grebien F,
Salah E,
Neudecker P,
Kay LE,
Turk BE,
Superti-Furga G,
Pawson T,
Knapp S.
Cell. 2008 Sep 5;134(5): 793–803.
2008
Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCRABL1 fusion protein kinases.
De Keersmaecker K,
Versele M,
Cools J,
Superti-Furga G,
Hantschel O.
Leukemia. 2008, Dec;22(12):2208–16.
2008
Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1–PDGFRalpha.
Baumgartner C,
Gleixner KV,
Peter B,
Ferenc V,
Gruze A,
Remsing Rix LL,
Bennett KL,
Samorapoompichit P,
Lee FY,
Pickl WF,
Esterbauer H,
Sillaber C,
Superti-Furga G,
Valent P.
Exp Hematol, 2008 Oct;36(10):1244–53.
2008
Analysis of cellular protein complexes by affinity purification and mass spectrometry.
Bürckstümmer T,
Bennett KL.
In Proteomics Methods Express 2008 (O’Connor CD and Hames BD, eds.), pp 119–134, Scion, Oxfordshire.
2007
Selective serotonin reuptake inhibitors – A new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol.
Schuster C,
Fernbach N,
Rix U,
Superti-Furga G,
Holy M,
Freissmuth M,
Sitte HH,
Sexl V.
2007, 74(9):1424–35.
2007
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib reveal novel kinase and non-kinase targets.
Rix U,
Hantschel O,
Dürnberger G,
Remsing Rix LL,
Planyavsky M,
Fernbach NV,
Kaupe I,
Bennett KL,
Valent P,
Colinge J,
Köcher T,
Superti-Furga G.
Blood. 2007, 110:4055–4063.
2007
The minimum information required for reporting a molecular interaction experiment (MIMIx).
Orchard S,
Salwinski L,
Kerrien S,
Montecchi- Palazzi L,
Oesterheld M,
Stumpflen V,
Ceol A,
Chatr-aryamontri A,
Armstrong J,
Woollard P,
Salama JJ,
Moore S,
Wojcik J,
Bader GD,
Vidal M,
Cusick ME,
Gerstein M,
Gavin AC,
Superti-Furga G,
et al.
Nat Biotechnol. 2007, 25(8):894–8.
2007
Mass spectrometry-based functional proteomics: from molecular machines to protein networks.
Kocher T,
Superti-Furga G.
Nat Methods. 2007, 4(10):807–15.
